Literature DB >> 21789664

Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto-inflammatory condition that mimics multiple classic radiographic findings.

Paul G Thacker1, Larry A Binkovitz, Kristen B Thomas.   

Abstract

Deficiency of interleukin-1-receptor antagonist (DIRA) syndrome is a newly identified inflammatory disease of the skeleton and appendicular soft tissues presenting in early infancy that has yet to be reported in the radiology literature. The radiological manifestations of DIRA syndrome include multifocal osteitis of the ribs and long bones, heterotopic ossification and periarticular soft-tissue swelling. Thus, the pediatric radiologist should be made aware of this novel disease because its radiographic findings can mimic multiple other disease entities. With knowledge of the unique clinical presentation of DIRA syndrome and its multiple radiographic manifestations, the pediatric radiologist may be the first to suggest the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789664     DOI: 10.1007/s00247-011-2208-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  5 in total

1.  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

Authors:  Ivona Aksentijevich; Seth L Masters; Polly J Ferguson; Paul Dancey; Joost Frenkel; Annet van Royen-Kerkhoff; Ron Laxer; Ulf Tedgård; Edward W Cowen; Tuyet-Hang Pham; Matthew Booty; Jacob D Estes; Netanya G Sandler; Nicole Plass; Deborah L Stone; Maria L Turner; Suvimol Hill; John A Butman; Rayfel Schneider; Paul Babyn; Hatem I El-Shanti; Elena Pope; Karyl Barron; Xinyu Bing; Arian Laurence; Chyi-Chia R Lee; Dawn Chapelle; Gillian I Clarke; Kamal Ohson; Marc Nicholson; Massimo Gadina; Barbara Yang; Benjamin D Korman; Peter K Gregersen; P Martin van Hagen; A Elisabeth Hak; Marjan Huizing; Proton Rahman; Daniel C Douek; Elaine F Remmers; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

2.  A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Authors:  Robert C Gensure; Outi Mäkitie; Catherine Barclay; Catherine Chan; Steven R Depalma; Murat Bastepe; Hilal Abuzahra; Richard Couper; Stefan Mundlos; David Sillence; Leena Ala Kokko; Jonathan G Seidman; William G Cole; Harald Jüppner
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  The skeletal manifestations of congenital syphilis. A review of 197 cases.

Authors:  M N Rasool; S Govender
Journal:  J Bone Joint Surg Br       Date:  1989-11

Review 4.  SAPHO: syndrome or concept? Imaging findings.

Authors:  J W S Earwaker; A Cotten
Journal:  Skeletal Radiol       Date:  2003-04-29       Impact factor: 2.199

5.  An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Authors:  Sreelatha Reddy; Shuang Jia; Rhonda Geoffrey; Rachel Lorier; Mariko Suchi; Ulrich Broeckel; Martin J Hessner; James Verbsky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

  5 in total
  5 in total

1.  The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.

Authors:  Micol Romano; Z Serap Arici; David Piskin; Sara Alehashemi; Daniel Aletaha; Karyl Barron; Susanne Benseler; Roberta A Berard; Lori Broderick; Fatma Dedeoglu; Michelle Diebold; Karen Durrant; Polly Ferguson; Dirk Foell; Jonathan S Hausmann; Olcay Y Jones; Daniel Kastner; Helen J Lachmann; Ronald M Laxer; Dorelia Rivera; Nicola Ruperto; Anna Simon; Marinka Twilt; Joost Frenkel; Hal M Hoffman; Adriana A de Jesus; Jasmin B Kuemmerle-Deschner; Seza Ozen; Marco Gattorno; Raphaela Goldbach-Mansky; Erkan Demirkaya
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

2.  Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.

Authors:  Ezgi Ulusoy; Neslihan Edeer Karaca; Hatem El-Shanti; Erhan Kilicoglu; Guzide Aksu; Necil Kutukculer
Journal:  J Med Case Rep       Date:  2015-06-23

Review 3.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

Review 4.  Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Luisa Costa; Mariangela Atteno; Adele Compagnone; Paolo Caso; Bruno Frediani; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Int J Rheumatol       Date:  2013-10-24

Review 5.  Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA.

Authors:  Francisco Gómez-García; Juan L Sanz-Cabanillas; Isabel Viguera-Guerra; Beatriz Isla-Tejera; Antonio Vélez-García Nieto; Juan Ruano
Journal:  Dermatol Ther (Heidelb)       Date:  2018-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.